期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

三阴性乳腺癌的病理与乳腺X线特征分析 被引量：1

下载PDF
导出
摘要 三阴性乳腺癌（TNBC）指雌激素受体（ER）、孕激素受体（PR）和人表皮生长因子受体-2（HER-2）均为阴性的乳腺癌。TNBC被认为是-种独立的临床类型，具有侵袭性强、预后差的特点。临床上如果能结合乳腺钼钯x线影像特点早期发现TNBC，无疑对手术前的治疗计划及判断预后有重要的指导意义。
作者 苏昆仑 徐海滨 崔凤 胡祖健 何俊玲 汤丽珠 杨欧欧
机构地区 浙江中医药大学附属广兴医院乳腺病科 浙江中医药大学附属广兴医院放射科
出处 《浙江医学》 CAS 2012年第16期1386-1387,1390,共3页 Zhejiang Medical Journal
基金 杭州市卫生科技计划一般（B）类项目（2011B013）
关键词 三阴性乳腺癌 X线特征 人表皮生长因子受体 病理 x线影像特点 临床类型 雌激素受体 孕激素受体
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献12

  • 1江泽飞,邵志敏,徐兵河.人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识[J].中华肿瘤杂志,2010,32(2):158-160. 被引量：47
  • 2乳腺癌HER2检测指南（2009版）[J].中华病理学杂志,2009,38(12):836-840. 被引量：192
  • 3Reis-Filho J S, Tutt A N. Triple negative tumours: a critical review[J]. Histopathology, 2008,52(1):108-118.
  • 4Ko E S, Lee B H, Kim H A, et al. Triple-negative breast cancer: cor- relation between imaging and pathological findings[J], Fur Radiol, 2010,20(5):1111-1117.
  • 5袁中玉,王树森,朱美琴,郑磊,罗文标,周中梅,管忠震.不同分子亚型乳腺癌的临床特征和预后[J].中华肿瘤杂志,2008,30(6):456-461. 被引量：55
  • 6Yang W T, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young pre- menopausal women[J]. Breast Cancer Res Treat, 2008,111(3):405- 410.
  • 7[Jematsu T, Kasami M, Yuen S. Triple-negative breast cancer: cor-relation between MR imaging and pathologic findings[J]. Radiology, 2009,250(3):638-647.
  • 8Schrading S, Kuhl C K. Mammographic, US, and MR imaging phe- notypes of familial breast cancer[J]. Radiology, 2008,246(1):58-70.
  • 9Evans A J, Pinder S E, Ellis I O, et al. Correlations between the mam- mographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression[J]. Clin Radiol, 1994,49(8):559-562.
  • 10Badra F A, Karamouzis M V, Ravazoula P, et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression[J]. Cancer Lett, 2006,244 (1):34-41.

二级参考文献42

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量：164
  • 2van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002, 415:530-536.
  • 3Sotiriou C, Neo SY, MeShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study. Proc Natl Acad Sci U S A, 2003, 100: 10393- 10398.
  • 4Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32.
  • 5Jones C, Nonni AV, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer, 2001, 85:422-427.
  • 6Cunningham JE, Butler WM. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat, 2004, 88 : 161-176.
  • 7Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295:2492-2502.
  • 8Lohrisch C, Piccart M. An overview of HER2. Semin Oncol, 2001, 28(6 Suppl 18) :3-11.
  • 9Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. J Clin Oncol, 2002, 20:2736-2744.
  • 10Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst, 2003, 95:1482-1485.

共引文献284

同被引文献15

  • 1Staudacher L, Cottu PH, Diras V, et al. Platinum- based chemo- therapy in metastatic triple-negative breast cancer:the Institut Curie experience[J]. Ann Oncol, 2011,22 (4) : 848-856.
  • 2Pern F, Bogdanova N, SshRmann P, et al. Mutation analysis of BRCA 1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer[J]. PLoS One, 2012,7 (10) : e47993.
  • 3Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk [J]. J A MA ,2012,307(13) : 1394-1404.
  • 4Geyer FC, Rodrigues DN, Weigeh B, et al. Molecular classifica- tion of estrogen receptor-positive/luminal breast cancers[J]. Adv Anat Pathol, 2012,19 ( 1 ) : 39-53.
  • 5Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pa- thologists clinical practice guideline update [J]. J Clin Oncol, 2013,31 (31) :3997-4013.
  • 6Gonzalez-Angulo AM ,Timms KM ,Liu S,et al. Incidenceand outcome of BRCA mutations in un selected patients with triple receptor-negative breast cancer [J]. Clin Cancer Res,2011,17 (5) : 1082-1089.
  • 7Yang P,Du C ,Kwan M,et al. The impact of P53 in predicting clinical outcome of breast cancer patients with visceral metasta- sis[J].Sci Rep, 2013,3 : 2246.
  • 8Nalwogah H, Aames JB, Stefansson IM, et al. Vascular prolifera- tions increased in basal-like breast cancer[J]. Breast Cancer Rse Treat, 2011,130(3) :1063-1071.
  • 9张勤,刘红.P53在三阴性乳腺癌中的表达及临床意义[J].中国肿瘤临床,2011,38(4):214-217. 被引量：26
  • 10郑荣寿,张思维,吴良有,李光琳,赵平,赫捷,陈万青.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12. 被引量：560

引证文献1

浙江医学
2012年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部